Michael Glynn has resigned as Pacific Biosciences' chief commercial officer. Glynn joined PacBio in October 2011 from Genzyme, where he served as regional president of Japan-Asia Pacific and senior vice president. He also held various roles at Boston Scientific and was CEO of Codman Group, a developer of healthcare decision support software and home telemedicine systems. He holds an MBA from Macquarie University in Sydney and a BS from the National University of Ireland.
Paired Ends: Michael Glynn
Aug 14, 2012